In one crossover study of healthy adults, two tablets labeled 4 mg each had plasma elimination half-lives of 0.95 hours (immediate release) and 1.63 hours (extended release).[3] In a separate study of 14 adults, plasma levels with a different prolonged-release tablet were about three times those with the immediate-release tablet at 4–6 hours.[2] These studies measured blood levels. They did not measure how long people slept or felt drowsy. NCCIH notes that in older people melatonin may stay active longer and cause daytime drowsiness.[1] All melatonin products contain the same molecule; extended-release forms are also labeled time-release, sustained-release or prolonged-release.[1]
On US labels
| Share of 1,218 US melatonin-only labels | |
|---|---|
| Name a slow, timed, sustained or extended release | 6% (76 labels)[1] |
| Tablets | 44%[1] |
| Capsules | 24%[1] |
| Gummies | 12%[1] |
| Liquids | 10%[1] |
| Lozenges | 5%[1] |
Our count of 1,218 US melatonin-only labels in the NIH Dietary Supplement Label Database (data release of 25 September 2025, counted 25 October 2026). Some tablets have two layers, one fast and one slow.[1]
What the two blood-level studies measured
| Study | Tablets compared | Time to the highest blood level (immediate / prolonged release) | Further measure | Funding |
|---|---|---|---|---|
| Mun and colleagues, crossover, 17 adults in the per-protocol analysis[3] | Two tablets labeled 4 mg each | 0.60 / 1.56 hours[3] | Elimination half-life 0.95 / 1.63 hours[3] | Pharmavite[3] |
| Román Martinez and colleagues, crossover, 14 healthy adults aged 20–45[2] | 1.99 mg immediate release and 1.98 mg prolonged release, single fasting doses | 0.75 / 0.50 hours (median)[2] | Blood exposure over 2–11 hours higher with the prolonged-release tablet; plasma levels about three times higher at 4–6 hours[2] | ITF Research Pharma[2] |
Each result describes the tablet tested in that study and its sampling times. Jet lag and sleep outcomes are covered on the melatonin guide and the jet lag page.
What the label lets you compare
- Release type. Look for words such as extended, timed or sustained release, or a two-layer tablet.[1]
- Amount per serving. Compare mg per serving; the label amount page explains servings and lab tests of content.
Before you choose a product
- Medicines. NCCIH advises people who take medicines to check with a health care provider before using melatonin, and notes that people with epilepsy or taking blood thinners need medical supervision.[1]
- Older adults. In older people, melatonin may stay active longer and cause daytime drowsiness.[1]
The melatonin guide and the page on melatonin or magnesium go further.
Information, not a prescription. Do not start, stop or combine supplements or medicines on your own.
More about melatonin
- Melatonin guide
- Melatonin or magnesium for sleep: which situations were studied?
- How was melatonin studied for jet lag?
- How close is the melatonin in a product to the amount on its label?
Sources
- NIH National Center for Complementary and Integrative Health. Melatonin: What You Need To Know. https://www.nccih.nih.gov/health/melatonin-what-you-need-to-know; NIH Dietary Supplement Label Database, US labels. https://dsld.od.nih.gov/ ↩
- Román Martinez M, and colleagues. Bioavailability of Oniria, a melatonin prolonged-release formulation, versus immediate-release melatonin in healthy volunteers. Drugs R D, 2022;22:235–243. https://doi.org/10.1007/s40268-022-00394-3 — PubMed 35918587. Several authors work for ITF Research Pharma, the product's maker. ↩
- Mun JG, and colleagues. Journal of Dietary Supplements. 2023. https://doi.org/10.1080/19390211.2023.2206475 — Funding: Pharmavite. ↩
You may quote, republish or translate this article under CC BY 4.0: credit “Verateca”, link to this page and indicate changes, including translations. Quotes from NIH, FDA and other sources, label texts and prices are not covered by this license.